An infant with ETV6-NTRK3 fusion-positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition

Pediatr Blood Cancer. 2020 Oct;67(10):e28628. doi: 10.1002/pbc.28628. Epub 2020 Aug 3.

Aditi Vedi^{1

2}, Katherine Holland³, Justin Cross⁴, Brinda Muthusamy⁵, Sam Behjati^{1

6}, C Elizabeth Hook⁷, Matthew J Murray^{1

8}

¹ Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
² Cambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Cambridge, UK.
³ Department of Neurosurgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁴ Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁵ Department of Paediatric Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁶ Wellcome Trust Sanger Institute, Hinxton, UK.
⁷ Department of Paediatric Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁸ Department of Pathology, University of Cambridge, Cambridge, UK.

No abstract available

Publication types